Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5

Class IIa histone deacetylases (HDACs) critically regulate cardiac function through the repression of the activity of myocyte enhancer factor 2 (MEF2)-dependent gene programs. Protein kinase D (PKD) and Ca2+/Calmodulin-dependent kinase II (CaMKII) activate MEF2 by phosphorylating distinct HDAC isofo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: He, Tao (VerfasserIn) , Huang, Jiale (VerfasserIn) , Chen, Lan (VerfasserIn) , Han, Gang (VerfasserIn) , Stanmore, David (VerfasserIn) , Krebs-Haupenthal, Jutta (VerfasserIn) , Avkiran, Metin (VerfasserIn) , Hagenmüller, Marco (VerfasserIn) , Backs, Johannes (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 May 2020
In: Journal of molecular and cellular cardiology
Year: 2020, Jahrgang: 145, Pages: 88-98
ISSN:1095-8584
DOI:10.1016/j.yjmcc.2020.05.018
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.yjmcc.2020.05.018
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0022282820302005
Volltext
Verfasserangaben:Tao He, Jiale Huang, Lan Chen, Gang Han, David Stanmore, Jutta Krebs-Haupenthal, Metin Avkiran, Marco Hagenmüller, Johannes Backs

MARC

LEADER 00000caa a2200000 c 4500
001 1742505406
003 DE-627
005 20230808092714.0
007 cr uuu---uuuuu
008 201210s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.yjmcc.2020.05.018  |2 doi 
035 |a (DE-627)1742505406 
035 |a (DE-599)KXP1742505406 
035 |a (OCoLC)1341383617 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a He, Tao  |d 1980-  |e VerfasserIn  |0 (DE-588)1067343318  |0 (DE-627)818649038  |0 (DE-576)426582179  |4 aut 
245 1 0 |a Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5  |c Tao He, Jiale Huang, Lan Chen, Gang Han, David Stanmore, Jutta Krebs-Haupenthal, Metin Avkiran, Marco Hagenmüller, Johannes Backs 
264 1 |c 30 May 2020 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.12.2020 
520 |a Class IIa histone deacetylases (HDACs) critically regulate cardiac function through the repression of the activity of myocyte enhancer factor 2 (MEF2)-dependent gene programs. Protein kinase D (PKD) and Ca2+/Calmodulin-dependent kinase II (CaMKII) activate MEF2 by phosphorylating distinct HDAC isoforms and thereby creating 14-3-3 binding sites for nucleo-cytoplasmic shuttling. Recently, it has been shown that this process is counteracted by cyclic AMP (cAMP)-dependent signaling. Here, we investigated the specific mechanisms of how cAMP-dependent signaling regulates distinct HDAC isoforms and determined their relative contributions to the protection from pathological MEF2 activation. We found that cAMP is sufficient to induce nuclear retention and to blunt phosphorylation of the 14-3-3 binding sites of HDAC5 (Ser259/498) and HDAC9 (Ser218/448) but not HDAC4 (Ser246/467/632). These regulatory events could be observed only in cardiomyocytes and myocyte-like cells but not in non-myocytes, pointing to an indirect myocyte-specific mode of action. Consistent with one previous report, we found that blunted phosphorylation of HDAC5 and HDAC9 was mediated by protein kinase A (PKA)-dependent inhibition of PKD. However, we show by the use of neonatal cardiomyocytes derived from genetic HDAC mouse models that endogenous HDAC5 but not HDAC9 contributes specifically to the repression of endogenous MEF2 activity. HDAC4 contributed significantly to the repression of MEF2 activity but based on the mechanistic findings of this study combined with previous results we attribute this to PKA-dependent proteolysis of HDAC4. Consistently, cAMP-induced repression of agonist-driven cellular hypertrophy was blunted in cardiomyocytes deficient for both HDAC5 and HDAC4. In conclusion, cAMP inhibits MEF2 through both nuclear accumulation of hypo-phosphorylated HDAC5 and through a distinct HDAC4-dependent mechanism. 
650 4 |a Cardiac hypertrophy 
650 4 |a Class IIa histone deacetylases 
650 4 |a Cyclic adenosine monophosphate 
650 4 |a Protein kinase A 
650 4 |a Protein kinase D 
700 1 |a Huang, Jiale  |d 1992-  |e VerfasserIn  |0 (DE-588)1298753554  |0 (DE-627)1854623494  |4 aut 
700 1 |a Chen, Lan  |e VerfasserIn  |0 (DE-588)1024916790  |0 (DE-627)720767199  |0 (DE-576)369681053  |4 aut 
700 1 |a Han, Gang  |e VerfasserIn  |4 aut 
700 1 |a Stanmore, David  |e VerfasserIn  |0 (DE-588)1069940275  |0 (DE-627)823053032  |0 (DE-576)429626762  |4 aut 
700 1 |a Krebs-Haupenthal, Jutta  |e VerfasserIn  |0 (DE-588)1059323575  |0 (DE-627)798300000  |0 (DE-576)415329590  |4 aut 
700 1 |a Avkiran, Metin  |e VerfasserIn  |4 aut 
700 1 |a Hagenmüller, Marco  |d 1974-  |e VerfasserIn  |0 (DE-588)1048599566  |0 (DE-627)780699041  |0 (DE-576)402443926  |4 aut 
700 1 |a Backs, Johannes  |d 1971-  |e VerfasserIn  |0 (DE-588)123819040  |0 (DE-627)706437462  |0 (DE-576)293892946  |4 aut 
773 0 8 |i Enthalten in  |t Journal of molecular and cellular cardiology  |d New York, NY [u.a.] : Elsevier, 1970  |g 145(2020), Seite 88-98  |h Online-Ressource  |w (DE-627)267328095  |w (DE-600)1469767-1  |w (DE-576)104193913  |x 1095-8584  |7 nnas  |a Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5 
773 1 8 |g volume:145  |g year:2020  |g pages:88-98  |g extent:11  |a Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5 
856 4 0 |u https://doi.org/10.1016/j.yjmcc.2020.05.018  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0022282820302005  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201210 
993 |a Article 
994 |a 2020 
998 |g 1048599566  |a Hagenmüller, Marco  |m 1048599566:Hagenmüller, Marco  |d 910000  |d 910100  |e 910000PH1048599566  |e 910100PH1048599566  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1059323575  |a Krebs-Haupenthal, Jutta  |m 1059323575:Krebs-Haupenthal, Jutta  |d 910000  |d 910100  |e 910000PK1059323575  |e 910100PK1059323575  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1069940275  |a Stanmore, David  |m 1069940275:Stanmore, David  |p 5 
998 |g 1024916790  |a Chen, Lan  |m 1024916790:Chen, Lan  |p 3 
998 |g 1298753554  |a Huang, Jiale  |m 1298753554:Huang, Jiale  |d 50000  |e 50000PH1298753554  |k 0/50000/  |p 2 
998 |g 1067343318  |a He, Tao  |m 1067343318:He, Tao  |d 910000  |d 910100  |e 910000PH1067343318  |e 910100PH1067343318  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1742505406  |e 3822538043 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1742505406"],"doi":["10.1016/j.yjmcc.2020.05.018"]},"language":["eng"],"physDesc":[{"extent":"11 S."}],"recId":"1742505406","note":["Gesehen am 10.12.2020"],"person":[{"given":"Tao","role":"aut","family":"He","display":"He, Tao","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Huang, Jiale","family":"Huang","given":"Jiale","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Chen, Lan","family":"Chen","given":"Lan","role":"aut"},{"display":"Han, Gang","family":"Han","roleDisplay":"VerfasserIn","given":"Gang","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Stanmore","display":"Stanmore, David","given":"David","role":"aut"},{"given":"Jutta","role":"aut","family":"Krebs-Haupenthal","display":"Krebs-Haupenthal, Jutta","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Avkiran, Metin","family":"Avkiran","given":"Metin","role":"aut"},{"family":"Hagenmüller","display":"Hagenmüller, Marco","roleDisplay":"VerfasserIn","role":"aut","given":"Marco"},{"given":"Johannes","role":"aut","roleDisplay":"VerfasserIn","display":"Backs, Johannes","family":"Backs"}],"title":[{"title_sort":"Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5","title":"Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"30 May 2020"}],"name":{"displayForm":["Tao He, Jiale Huang, Lan Chen, Gang Han, David Stanmore, Jutta Krebs-Haupenthal, Metin Avkiran, Marco Hagenmüller, Johannes Backs"]},"relHost":[{"name":{"displayForm":["International Society for Heart Research"]},"part":{"volume":"145","year":"2020","extent":"11","text":"145(2020), Seite 88-98","pages":"88-98"},"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"International Society for Heart Research"}],"origin":[{"dateIssuedKey":"1970","publisherPlace":"New York, NY [u.a.] ; London","dateIssuedDisp":"1970-","publisher":"Elsevier ; Academic Press"}],"disp":"Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5Journal of molecular and cellular cardiology","pubHistory":["1.1970 -"],"note":["Gesehen am 21.01.20","Ungezählte Beil.: Supplement"],"title":[{"title":"Journal of molecular and cellular cardiology","title_sort":"Journal of molecular and cellular cardiology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"id":{"eki":["267328095"],"issn":["1095-8584"],"zdb":["1469767-1"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"267328095"}]} 
SRT |a HETAOHUANGCYCLICAMPR3020